Literature DB >> 12901721

Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus.

Jennifer Kovacs-Nolan1, Dongwan Yoo, Yoshinori Mine.   

Abstract

The epitopes of the HRV (human rotavirus), especially those involved in virus neutralization, have not been determined in their entirety, and would have significant implications for HRV vaccine development. In the present study, we report on the epitope mapping and identification of sequential neutralization epitopes, on the Wa strain HRV subunit protein VP8, using synthetic overlapping peptides. Polyclonal antibodies against recombinant Wa VP8 were produced previously in chicken, and purified from egg yolk, which showed neutralizing activity against HRV in vitro. Overlapping VP8 peptide fragments were synthesized and probed with the anti-VP8 antibodies, revealing five sequential epitopes on VP8. Further analysis suggested that three of the five epitopes detected, M1-L10, I55-D66 and L223-P234, were involved in virus neutralization, indicating that sequential epitopes may also be important for the HRV neutralization. The interactions of the antibodies with the five epitopes were characterized by an examination of the critical amino acids involved in antibody binding. Epitopes comprised primarily of hydrophobic amino acid residues, followed by polar and charged residues. The more critical amino acids appeared to be located near the centre of the epitopes, with proline, isoleucine, serine, glutamine and arginine playing an important role in the binding of antibody to the VP8 epitopes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901721      PMCID: PMC1223744          DOI: 10.1042/BJ20021969

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.

Authors:  Y J Zhou; J W Burns; Y Morita; T Tanaka; M K Estes
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

2.  SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes.

Authors:  R Frank; H Overwin
Journal:  Methods Mol Biol       Date:  1996

3.  Rotavirus structure: interactions between the structural proteins.

Authors:  A L Shaw; R Rothnagel; C Q Zeng; J A Lawton; R F Ramig; M K Estes; B V Prasad
Journal:  Arch Virol Suppl       Date:  1996

Review 4.  Rotavirus vaccine, live, oral, tetravalent (RotaShield).

Authors:  C Hochwald; L Kivela
Journal:  Pediatr Nurs       Date:  1999 Mar-Apr

5.  Cleavage of rotavirus VP4 in vivo.

Authors:  J E Ludert; A A Krishnaney; J W Burns; P T Vo; H B Greenberg
Journal:  J Gen Virol       Date:  1996-03       Impact factor: 3.891

Review 6.  The rotavirus genome.

Authors:  U Desselberger; M A McCrae
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

7.  Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.

Authors:  A M Giammarioli; E R Mackow; L Fiore; H B Greenberg; F M Ruggeri
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

8.  Functional and structural analysis of the sialic acid-binding domain of rotaviruses.

Authors:  P Isa; S López; L Segovia; C F Arias
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3.

Authors:  L Padilla-Noriega; S J Dunn; S López; H B Greenberg; C F Arias
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

View more
  7 in total

1.  Norovirus P particle, a novel platform for vaccine development and antibody production.

Authors:  Ming Tan; Pengwei Huang; Ming Xia; Ping-An Fang; Weiming Zhong; Monica McNeal; Chao Wei; Wen Jiang; Xi Jiang
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy.

Authors:  Filippo Ansaldi; Barbara Pastorino; Laura Valle; Paolo Durando; Laura Sticchi; Pierluigi Tucci; Paolo Biasci; Piero Lai; Roberto Gasparini; Giancarlo Icardi
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

3.  A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins.

Authors:  Yumei Teng; Bingxin Zhao; Xiaoxia Pan; Yuling Wen; Yuanding Chen
Journal:  Viral Immunol       Date:  2014-04-04       Impact factor: 2.257

4.  Design strategies to address the effect of hydrophobic epitope on stability and in vitro assembly of modular virus-like particle.

Authors:  Alemu Tekewe; Natalie K Connors; Anton P J Middelberg; Linda H L Lua
Journal:  Protein Sci       Date:  2016-06-13       Impact factor: 6.725

5.  A dual chicken IgY against rotavirus and norovirus.

Authors:  Ying-Chun Dai; Xu-Fu Zhang; Ming Tan; Pengwei Huang; Wen Lei; Hao Fang; Weiming Zhong; Xi Jiang
Journal:  Antiviral Res       Date:  2012-12-22       Impact factor: 5.970

6.  Passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice.

Authors:  Jenn-Fa Liou; Chih-Wei Chang; Jui-jane Tailiu; Chun-Keung Yu; Huan-Yao Lei; Lih-Ren Chen; Chein Tai
Journal:  Vaccine       Date:  2010-10-29       Impact factor: 3.641

7.  Novel antigen panel for modern broad-spectrum recombinant rotavirus A vaccine.

Authors:  Olga A Kondakova; Peter A Ivanov; Oleg A Baranov; Ekaterina M Ryabchevskaya; Marina V Arkhipenko; Eugene V Skurat; Ekaterina A Evtushenko; Nikolai A Nikitin; Olga V Karpova
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.